Balanced news tone
News Sentiment
AFX sentiment intelligence
Carl Zeiss Meditec AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
+4.7% over one week, +21.0% over four weeks, trend inactive, and below fair value.
CARL ZEISS MEDITEC AG : JP Morgan maintains a Sell rating
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
CARL ZEISS MEDITEC AG : JP Morgan maintains a Sell rating
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 17 Jul 2026 06:17
- Source
- marketscreener.com
Enterprise value to revenue forward of Carl Zeiss Meditec AG – DUS:AFX
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 21:25
- Source
- TradingView
Carl Zeiss Meditec (XTRA:AFX) Refines Manufacturing Analytics, Is It A Bargain?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 16:01
- Source
- simplywall.st
Carl Zeiss to increase stake in medical technology subsidiary
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 22 Jun 2026 07:00
- Source
- marketscreener.com
Carl Zeiss Meditec (XTRA:AFX) Margin Compression To 4.4% Tests Bullish Earnings Recovery Narrative
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- simplywall.st
Carl Zeiss Meditec erases nearly all previous session gains
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- marketscreener.com
CARL ZEISS MEDITEC AG : Barclays is Neutral
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- marketscreener.com
CARL ZEISS MEDITEC AG : UBS is Neutral
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- marketscreener.com
How Carl Zeiss Meditec’s New Crossbeam 750 FIB-SEM At Carl Zeiss Meditec (XTRA:AFX) Has Changed Its Investment Story
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Apr 2026 07:00
- Source
- simplywall.st
Has Carl Zeiss Meditec (XTRA:AFX) Fallen Too Far After Recent Medtech Reassessment?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Feb 2026 08:00
- Source
- Market source
Is Carl Zeiss Meditec (XTRA:AFX) Offering Opportunity After A 52% One Year Share Price Slump
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 25 Feb 2026 08:00
- Source
- simplywall.st
Carl Zeiss Meditec's (ETR:AFX) Dividend Will Be Reduced To €0.55
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 10 Feb 2026 08:00
- Source
- simplywall.st
Bernstein downgrades Carl Zeiss Meditec stock rating amid profit warning By Investing.com
- Tone
- Negative 31/100
- Event
- Earnings
- Published
- 26 Jan 2026 08:00
- Source
- Investing.com Nigeria
Carl Zeiss Meditec AG (ETR:AFX) Stocks Pounded By 27% But Not Lagging Market On Growth Or Pricing
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 23 Jan 2026 08:00
- Source
- simplywall.st
Carl Zeiss Hits Ten-Year Low After Weak Business Signals
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 22 Jan 2026 08:00
- Source
- marketscreener.com
Investors in Carl Zeiss Meditec (ETR:AFX) have unfortunately lost 68% over the last three years
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jan 2026 08:00
- Source
- Market source
Here's What Analysts Are Forecasting For Carl Zeiss Meditec AG (ETR:AFX) After Its Full-Year Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Dec 2025 08:00
- Source
- Market source
Is It Too Late To Consider Buying Carl Zeiss Meditec AG (ETR:AFX)?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Dec 2025 08:00
- Source
- simplywall.st
A Fresh Look at Carl Zeiss Meditec (XTRA:AFX) Valuation Following Major Ophthalmic Technology Reveals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Sep 2025 07:00
- Source
- simplywall.st
JPMorgan leaves Carl Zeiss Meditec at 'Underweight'
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 30 Aug 2024 07:00
- Source
- marketscreener.com
Carl Zeiss Meditec AG: Financial Data Forecasts Estimates and Expectations | AFX | DE0005313704
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2023 06:19
- Source
- marketscreener.com
Carl Zeiss Meditec AG: Target Price Consensus and Analysts Recommendations | AFX | DE0005313704
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 18 Aug 2020 17:30
- Source
- marketscreener.com